MAIA Biotechnology (MAIA) Common Equity (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Common Equity of $27.8 million for Q1 2026, up 461.71% year-over-year from $4.9 million in Q1 2025, and up 1068.53% quarter-over-quarter from $2.4 million in Q4 2025.
MAIA Biotechnology (MAIA) Common Equity (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Common Equity for 6 consecutive years, with $27.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity rose 461.71% year-over-year to $27.8 million; the TTM figure through Mar 2026 stood at $27.8 million (up 461.71% YoY), while the FY2025 annual figure was $2.4 million, down 34.63% from the prior year.
- Common Equity improved to $27.8 million in Q1 2026 per MAIA's latest filing, from $2.4 million in the prior quarter.
- Across five years, Common Equity topped out at $27.8 million in Q1 2026 and bottomed at -$5.8 million in Q1 2024.
- Historically, Common Equity has averaged $5.5 million across 5 years, with a median of $3.9 million in 2025.
- On a YoY basis, Common Equity climbed as much as 661.16% in 2024 and fell as far as 213.41% in 2024.
- MAIA Biotechnology's Common Equity stood at $8.5 million in 2022, then slumped by 94.39% to $477511.0 in 2023, then surged by 661.16% to $3.6 million in 2024, then plunged by 34.63% to $2.4 million in 2025, then surged by 1068.53% to $27.8 million in 2026.
- Business Quant data shows MAIA's Common Equity at $27.8 million in Q1 2026, $2.4 million in Q4 2025, and $41670.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.79 Bn |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | 20.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.68 Mn |
| Mar 31, 2026 | 27.76 Mn |
| Dec 31, 2025 | 2.38 Mn |
| Sep 30, 2025 | 41,670.00 |
| Jun 30, 2025 | 3.88 Mn |
| Mar 31, 2025 | 4.94 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 3.16 Mn |
| Mar 31, 2024 | -5.76 Mn |
| Dec 31, 2023 | 477,511.00 |
| Sep 30, 2023 | 2.75 Mn |
| Jun 30, 2023 | 6.87 Mn |
| Mar 31, 2023 | 5.08 Mn |
| Dec 31, 2022 | 8.51 Mn |
| Sep 30, 2022 | 12.11 Mn |
| Jun 30, 2022 | 6.66 Mn |
| Mar 31, 2022 | 9.01 Mn |
| Dec 31, 2021 | 9.18 Mn |
| Sep 30, 2021 | 10.23 Mn |